Delivery Order SPE2DB22D3301-SPE2DB24FZ0QM

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $5.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,044.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562592259 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of October 26, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program....
This federal contract award, valued at $7,233.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4567361463 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a period of performance through February 25, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,555.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $5,136.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of 4566304062 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of November 4, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,759.57, is for the delivery of 4562661892 CLOBAZAM 10 MG TABLET 100S and has an ultimate completion date of November 1, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,624.73, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $1,565.53, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562966683 CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a period of performance through December 4, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation, indicating open...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564689868 - CLOBAZAM 10 MG TABLET 100S. The contract is a Delivery Order with a Firm Fixed Price of $1,592.62 and an ultimate completion date of May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $18,815.01, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a performance period ending on July 22, 2024 and utilizes a Firm Fixed Price pricing structure. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,608.79 firm fixed-price Delivery Order is for the supply of 4565263325 - CLOBAZAM 10 MG TABLET 100S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ0QM
    Delivery Order

This federal contract award, valued at $5,518.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565154069 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has a Firm Fixed Price pricing type and a completion date of July 16, 2024. There is no set-aside designation for this award.

Generated 10/14/24, 10:06 AM